Medication info
Janua Tablet 50 mg (Sitagliptin Hydrochloride Monohydrate)

Janua Tablet 50 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Il Yang Pharmaceutical Co., Ltd.
Appearance
Light yellowish pink, round, biconvex film-coated tablet
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 202004065 · Approved 2020.05.29 · Insurance code 641706160

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This drug is administered once daily at a dose of 100 mg as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This drug may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see section 5. General Precautions, under Precautions for Use). Patients with renal impairment Since dosage adjustment is required according to renal function, evaluation of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Il Yang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in controlling blood sugar in patients with type 2 diabetes
View approved original text

This medication is used alongside dietary management and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone for initial treatment, and if blood sugar control is insufficient, it can be combined with other diabetic medications like Metformin. Additionally, it can be used in combination with various monotherapy or combination treatments that are ineffective in controlling blood sugar. This flexible approach allows for stepwise treatment to improve blood sugar management.

How to take

Adult dose

This drug is administered once daily at a dose of 100 mg as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This drug may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see section 5. General Precautions, under Precautions for Use). Patients with renal impairment Since dosage adjustment is required according to renal function, evaluation of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions. If symptoms such as a skin rash, difficulty in breathing, or swelling of the face or neck occur, discontinue use immediately and consult a physician. During treatment with this medication, there may be occurrences of acute pancreatitis, which is inflammation of the pancreas, so if symptoms such as abdominal pain, vomiting, or nausea appear, notify a healthcare professional immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should not be taken by patients who are allergic to this medication or its components. Patients with impaired kidney function may experience slower excretion of the medication, so the dose should be adjusted according to a physician's instructions, and regular kidney function tests are important. While taking this medication, side effects such as upper respiratory infections, headache, pharyngitis, diarrhea, and nausea may occur; if symptoms persist or worsen, consult a physician. Especially when used in conjunction with insulin or sulfonylureas, there may be an increased risk of hypoglycemia, so blood sugar levels should be regularly monitored and dose adjustments should be made according to a physician's directions as needed. Rare side effects like severe joint pain or bullous pemphigoid, which may present as blisters on the skin, have been reported; if these symptoms occur, discontinue use immediately and notify healthcare personnel. It is not recommended for women who are pregnant or breastfeeding, and safety and efficacy have not been established in children or adolescents under 18 years of age. In the case of overdose, general treatment should be provided to remove the drug from the gastrointestinal tract and monitor the electrocardiogram; some drugs may be removed through hemodialysis if necessary. This medication generally has low interactions with other drugs, but if taken with cyclosporine or digoxin, appropriate monitoring in consultation with healthcare professionals is required. Elderly patients may have a decline in kidney function, so dose adjustments and monitoring of kidney function are important, and if any abnormal symptoms occur, they should notify healthcare personnel immediately.

Side effects

Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, joint pain accompanied by severe symptoms and disabilities, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzyme levels, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, elevated serum triglycerides, gastritis, increased low-density lipoprotein, hyperglycemia, weight loss, hypertension, hypernatremia, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent air and moisture from entering. It is also recommended to store it at a room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

Light yellowish pink, round, biconvex film-coated tablet

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.